OrthoPediatrics (KIDS) vs SpyGlass Pharma (SGP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
SpyGlass Pharma is the larger company by market cap ($823.5 million vs $568.1 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KIDS | SGP |
|---|---|---|
| Share price | $21.76 | $24.62 |
| Market cap | $568.15M | $823.49M |
| 1-day change | -3.20% | +3.01% |
| YTD return | +22.52% | — |
| 1-year return | +20.22% | — |
| 5-year return | -65.42% | — |
| EPS (TTM) | $-1.68 | $-2.51 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.74 | $32.44 |
| 52-week low | $14.42 | $17.06 |
| Distance from 52-week high | -18.62% | -24.11% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +25.09% | +78.72% |
| Average volume | 209.38K | 110.00K |
| Shares outstanding | 26.11M | 33.45M |
| Employees | 602 | 76 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About OrthoPediatrics
KIDS stock →OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Health Care · Medical/Dental Instruments · 602 employees
About SpyGlass Pharma
SGP stock →SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions.
Health Care · Medical/Dental Instruments · 76 employees
KIDS vs SGP FAQ
Which is bigger, OrthoPediatrics or SpyGlass Pharma?
SpyGlass Pharma (SGP) is larger, with a market capitalization of $823.49M compared with $568.15M for OrthoPediatrics (KIDS).
Are OrthoPediatrics and SpyGlass Pharma in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.